M. Lejeune, Estimation paramétrique par intervalle de confiance, Statistique, pp.135-166, 2010.

M. Lejeune, Estimation paramétrique par intervalle de confiance, Statistique, pp.135-166, 2010.

G. Virgili, G. Gatta, L. Ciccolallo, R. Capocaccia, A. Biggeri et al., Incidence of Uveal Melanoma in Europe, Ophthalmology, vol.114, issue.12, pp.2309-2315.e2, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00492638

C. C. Mclaughlin, X. Wu, A. Jemal, H. J. Martin, L. M. Roche et al., Incidence of noncutaneous melanomas in the U.S., Cancer, vol.103, issue.5, pp.1000-1007, 2005.

R. D. Carvajal, G. K. Schwartz, T. Tezel, B. Marr, J. H. Francis et al., Metastatic disease from uveal melanoma: treatment options and future prospects, British Journal of Ophthalmology, vol.101, issue.1, pp.38-44, 2016.

A. E. Chang, L. H. Karnell, and H. R. Menck, The National Cancer Data Base report on cutaneous and noncutaneous melanoma, Cancer, vol.83, issue.8, pp.1664-1678, 1998.

N. Cassoux, M. J. Rodrigues, C. Plancher, B. Asselain, C. Levy-gabriel et al., Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma, British Journal of Ophthalmology, vol.98, issue.6, pp.769-774, 2013.

S. S. Agarwala, A. M. Eggermont, S. O'day, and J. S. Zager, Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options, Cancer, vol.120, issue.6, pp.781-789, 2013.

P. Mariani, V. Servois, and S. Piperno-neumann, Therapeutic Options in Metastatic Uveal Melanoma, Current Concepts in Uveal Melanoma, vol.49, pp.166-181, 2011.

E. Kujala, T. Ma¨kitie, and T. Kivela¨, Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma, Investigative Opthalmology & Visual Science, vol.44, issue.11, p.4651, 2003.

P. Mariani, S. Piperno-neumann, V. Servois, M. G. Berry, T. Dorval et al., Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie, European Journal of Surgical Oncology (EJSO), vol.35, issue.11, pp.1192-1197, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00556287

S. Piperno-neumann, V. Servois, P. Mariani, C. Plancher, C. Lévy-gabriel et al., Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients, Journal Français d'Ophtalmologie, vol.38, issue.6, pp.526-534, 2015.

M. Wagner, P. Mariani, F. C. Bidard, M. J. Rodrigues, F. Farkhondeh et al., Diffusion-weighted MRI for uveal melanoma liver metastasis detection, European Radiology, vol.25, issue.8, pp.2263-2273, 2015.

M. Wagner, P. Mariani, F. C. Bidard, M. J. Rodrigues, F. Farkhondeh et al., Diffusion-weighted MRI for uveal melanoma liver metastasis detection, European Radiology, vol.25, issue.8, pp.2263-2273, 2015.

D. Löwenthal, M. Zeile, W. Y. Lim, C. Wybranski, F. Fischbach et al., Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging, European Radiology, vol.21, issue.4, pp.832-840, 2010.

V. Vilgrain, M. Esvan, M. Ronot, A. Caumont-prim, C. Aubé et al., A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases, European Radiology, vol.26, issue.12, pp.4595-4615, 2016.

A. Hiwatashi, T. Kinoshita, T. Moritani, H. Z. Wang, D. A. Shrier et al., Hypointensity on Diffusion-Weighted MRI of the Brain Related to T2 Shortening and Susceptibility Effects, American Journal of Roentgenology, vol.181, issue.6, pp.1705-1709, 2003.

B. A. Krantz, N. Dave, K. M. Komatsubara, B. P. Marr, and R. D. Carvajal, Uveal melanoma: epidemiology, etiology, and treatment of primary disease, Clinical Ophthalmology, vol.Volume 11, pp.279-289, 2017.

E. Wöll, A. Bedikian, and S. S. Legha, Uveal melanoma, Melanoma Research, vol.9, issue.6, pp.575-582, 1999.

S. Kaliki and C. L. Shields, Uveal melanoma: relatively rare but deadly cancer, Eye, vol.31, issue.2, pp.241-257, 2016.

R. Balasubramanya, S. K. Selvarajan, M. Cox, G. Joshi, S. Deshmukh et al., Imaging of ocular melanoma metastasis, The British Journal of Radiology, vol.89, issue.1065, p.20160092, 2016.

M. D. Onken, L. A. Worley, J. P. Ehlers, and J. W. Harbour, Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death, Cancer Research, vol.64, issue.20, pp.7205-7209, 2004.

D. Kuk, A. N. Shoushtari, C. A. Barker, K. S. Panageas, R. R. Munhoz et al., Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis, The Oncologist, vol.21, issue.7, pp.848-854, 2016.

C. L. Shields, S. Kaliki, M. Livesey, B. Walker, R. Garoon et al., Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis, JAMA Ophthalmology, vol.131, issue.8, p.993, 2013.

E. Weis, C. P. Shah, M. Lajous, J. A. Shields, and C. L. Shields, The Association Between Host Susceptibility Factors and Uveal Melanoma, Archives of Ophthalmology, vol.124, issue.1, p.54, 2006.

M. D. Onken, L. A. Worley, D. H. Char, J. J. Augsburger, Z. M. Correa et al., Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma, Ophthalmology, vol.119, issue.8, pp.1596-1603, 2012.

L. Desjardins and L. Meziani, Faculty Opinions recommendation of Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma., Ophthalmology. août, vol.119, issue.8, pp.1596-603, 2012.

C. P. Shah, E. Weis, M. Lajous, J. A. Shields, and C. L. Shields, Intermittent and Chronic Ultraviolet Light Exposure and Uveal Melanoma, Ophthalmology, vol.112, issue.9, pp.1599-1607, 2005.

J. J. Park, R. J. Diefenbach, A. M. Joshua, R. F. Kefford, M. S. Carlino et al., Oncogenic signaling in uveal melanoma, Pigment Cell & Melanoma Research, vol.31, issue.6, pp.661-672, 2018.

C. D. Van-raamsdonk, V. Bezrookove, G. Green, J. Bauer, L. Gaugler et al., Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, vol.457, issue.7229, pp.599-602, 2008.

E. M. Damato, B. E. Damato, C. L. Shields, M. Furuta, A. Thangappan et al., Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients, Arch Ophthalmol Chic Ill, vol.119, issue.8, pp.989-98, 1960.

T. A. Mccannel, Fine-needle aspiration biopsy in the management of choroidal melanoma, Current Opinion in Ophthalmology, vol.24, issue.3, pp.262-266, 2013.

T. A. Mccannel, M. Y. Chang, and B. L. Burgess, Multi-Year Follow-up of Fine-Needle Aspiration Biopsy in Choroidal Melanoma, Ophthalmology, vol.119, issue.3, pp.606-610, 2012.

I. W. Mclean, W. D. Foster, L. E. Zimmerman, and J. W. Gamel, Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of Pathology, American Journal of Ophthalmology, vol.195, pp.lvi-lx, 2018.

S. Kaliki, C. L. Shields, and J. A. Shields, Uveal melanoma: Estimating prognosis, Indian Journal of Ophthalmology, vol.63, issue.2, p.93, 2015.

E. R. Simpson, B. L. Gallie, S. Saakyan, A. Amiryan, P. T. Finger et al., International Validation of the American Joint Committee on Cancer?s 7th Edition Classification of Uveal Melanoma, JAMA Ophthalmology, vol.133, issue.4, p.376, 2015.

C. L. Shields, S. Kaliki, M. Furuta, E. Fulco, C. Alarcon et al., American Joint Committee on Cancer Classification of Posterior Uveal Melanoma (Tumor Size Category) Predicts Prognosis in 7731 Patients, Ophthalmology, vol.120, issue.10, pp.2066-2071, 2013.

C. L. Shields, S. Kaliki, M. Furuta, A. Mashayekhi, and J. A. Shields, CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES, Retina, vol.32, issue.7, pp.1363-1372, 2012.

O. Zloto, J. Pe'er, and S. Frenkel, Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma, Investigative Opthalmology & Visual Science, vol.54, issue.1, p.652, 2013.

K. G. Ewens, P. A. Kanetsky, J. Richards-yutz, S. Al-dahmash, M. C. De-luca et al., Genomic Profile of 320 Uveal Melanoma Cases: Chromosome 8p-Loss and Metastatic Outcome, Investigative Opthalmology & Visual Science, vol.54, issue.8, p.5721, 2013.

J. W. Harbour, A Prognostic Test to Predict the Risk of Metastasis in Uveal Melanoma Based on a 15-Gene Expression Profile, Methods in Molecular Biology, vol.1102, pp.427-440, 2013.

J. W. Harbour, M. D. Onken, E. D. Roberson, S. Duan, L. Cao et al., Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas, Science, vol.330, issue.6009, pp.1410-1413, 2010.

S. J. Furney, M. Pedersen, D. Gentien, A. G. Dumont, A. Rapinat et al., SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma, Cancer Discovery, vol.3, issue.10, pp.1122-1129, 2013.

E. Szalai, Y. Jiang, N. M. Van-poppelen, M. J. Jager, A. De-klein et al., Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation, JAMA Ophthalmology, vol.136, issue.10, p.1115, 2018.

M. J. Vader, M. C. Madigan, M. Versluis, H. M. Suleiman, G. Gezgin et al., GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi, British Journal of Cancer, vol.117, issue.6, pp.884-887, 2017.

A. G. Robertson, J. Shih, C. Yau, E. A. Gibb, J. Oba et al., Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma, Cancer Cell, vol.33, issue.1, p.151, 2018.

A. M. Rose, S. Cowen, C. N. Jayasena, D. H. Verity, and G. E. Rose, Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit, Frontiers in Oncology, vol.7, p.125, 2017.

M. Diener-west, S. M. Reynolds, D. J. Agugliaro, R. Caldwell, K. Cumming et al., Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma, Archives of Ophthalmology, vol.123, issue.12, p.1639, 2005.

M. Diener-west, S. M. Reynolds, D. J. Agugliaro, R. Caldwell, K. Cumming et al., Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma, Archives of Ophthalmology, vol.123, issue.12, p.1639, 2005.

P. L. Triozzi and A. D. Singh, Adjuvant Therapy of Uveal Melanoma: Current Status, Ocular Oncology and Pathology, vol.1, issue.1, pp.54-62, 2015.

D. M. Buzzacco, M. H. Abdel-rahman, S. Park, F. Davidorf, T. Olencki et al., Long-Term Survivors with Metastatic Uveal Melanoma, The Open Ophthalmology Journal, vol.6, issue.1, pp.49-53, 2012.

S. Leyvraz, S. Piperno-neumann, S. Suciu, J. F. Baurain, M. Zdzienicki et al., Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial, Annals of Oncology, vol.25, issue.3, pp.742-746, 2014.

S. Leyvraz, S. Piperno-neumann, S. Suciu, J. F. Baurain, M. Zdzienicki et al., Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial, Annals of Oncology, vol.25, issue.3, pp.742-746, 2014.

M. Maio, R. Danielli, V. Chiarion-sileni, J. Pigozzo, G. Parmiani et al., Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma, Annals of Oncology, vol.24, issue.11, pp.2911-2915, 2013.

K. M. Komatsubara and R. D. Carvajal, Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies, Current Oncology Reports, vol.19, issue.7, p.45, 2017.

J. S. Weber, S. P. D'angelo, D. Minor, F. S. Hodi, R. Gutzmer et al., Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial, The Lancet Oncology, vol.16, issue.4, pp.375-384, 2015.

L. A. Kottschade, R. R. Mcwilliams, S. N. Markovic, M. S. Block, J. Villasboas-bisneto et al., The use of pembrolizumab for the treatment of metastatic uveal melanoma, Melanoma Research, vol.26, issue.3, pp.300-303, 2016.

A. P. Algazi, K. K. Tsai, A. N. Shoushtari, R. R. Munhoz, Z. Eroglu et al., Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies, Cancer, vol.122, issue.21, pp.3344-3353, 2016.

E. C. Hsueh, R. Essner, L. J. Foshag, X. Ye, H. Wang et al., Prolonged survival after complete resection of metastases from intraocular melanoma, Cancer, vol.100, issue.1, pp.122-129, 2003.

P. Mariani, M. M. Almubarak, M. Kollen, M. Wagner, C. Plancher et al., Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma, European Journal of Surgical Oncology (EJSO), vol.42, issue.5, pp.706-712, 2016.

P. Mariani, M. M. Almubarak, M. Kollen, M. Wagner, C. Plancher et al., Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma, European Journal of Surgical Oncology (EJSO), vol.42, issue.5, pp.706-712, 2016.

P. Pilati, European Journal of Surgical Oncology, vol.0, issue.0, pp.1-10, 2002.

M. M. Choudhary, A. Gupta, J. Bena, T. Emch, and A. D. Singh, Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma, JAMA Ophthalmology, vol.134, issue.2, p.174, 2016.

S. Eskelin, S. Pyrh?nen, P. Summanen, J. U. Prause, and T. Kivel?, Screening for metastatic malignant melanoma of the uvea revisited, Cancer, vol.85, issue.5, pp.1151-1159, 1999.

J. J. Augsburger, Z. M. Corrêa, and N. Trichopoulos, Surveillance Testing for Metastasis From Primary Uveal Melanoma and Effect on Patient Survival, American Journal of Ophthalmology, vol.152, issue.1, pp.5-9.e1, 2011.

Y. Ko, J. Kim, J. Park, H. Kim, J. Y. Cho et al., Limited detection of small (? 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection, PLOS ONE, vol.12, issue.12, p.e0189797, 2017.

E. G. Feinstein, B. P. Marr, C. B. Winston, and D. H. Abramson, Hepatic Abnormalities Identified on Abdominal Computed Tomography at Diagnosis of Uveal Melanoma, Archives of Ophthalmology, vol.128, issue.3, p.319, 2010.

M. Patel, C. B. Winston, B. P. Marr, R. D. Carvajal, G. K. Schwartz et al., Characterization of Computed Tomography Scan Abnormalities in Patients With Biopsy-Proven Hepatic Metastases From Uveal Melanoma, Archives of Ophthalmology, vol.129, issue.12, p.1576, 2011.

R. Hammerstingl, A. Huppertz, J. Breuer, T. Balzer, A. Blakeborough et al., Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions, European Radiology, vol.18, issue.3, pp.457-467, 2007.

A. B. Francken, M. J. Fulham, M. J. Millward, and J. F. Thompson, Detection of metastatic disease in patients with uveal melanoma using positron emission tomography, European Journal of Surgical Oncology (EJSO), vol.32, issue.7, pp.780-784, 2006.

V. Servois, P. Mariani, C. Malhaire, S. Petras, S. Piperno-neumann et al., Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET), European Journal of Surgical Oncology (EJSO), vol.36, issue.2, pp.189-194, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00557766

K. Strobel, B. Bode, R. Dummer, P. Veit-haibach, D. R. Fischer et al., Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.36, issue.11, pp.1774-1782, 2009.

K. Coenegrachts, Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions, World Journal of Radiology, vol.1, issue.1, p.72, 2009.

M. C. Niekel, S. Bipat, and J. Stoker, Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment, Radiology, vol.257, issue.3, pp.674-684, 2010.

M. Ronot, A. K. Clift, R. P. Baum, A. Singh, H. R. Kulkarni et al., Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases, Neuroendocrinology, vol.106, issue.1, pp.74-88, 2017.

E. Marshall, C. Romaniuk, P. Ghaneh, H. Wong, M. Mckay et al., MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients, British Journal of Ophthalmology, vol.97, issue.2, pp.159-163, 2012.

S. Kawahara, H. Isoda, K. Fujimoto, H. Shimizu, A. Furuta et al., Additional benefit of computed diffusion-weighted imaging for detection of hepatic metastases at 1.5T, Clinical Imaging, vol.40, issue.3, pp.481-485, 2016.

K. Coenegrachts, J. Delanote, L. Ter-beek, M. Haspeslagh, S. Bipat et al., Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shotT2weighted turbo spin echo techniques, The British Journal of Radiology, vol.80, issue.955, pp.524-531, 2007.

M. Eiber, A. A. Fingerle, M. Brügel, J. Gaa, E. J. Rummeny et al., Detection and classification of focal liver lesions in patients with colorectal cancer: Retrospective comparison of diffusion-weighted MR imaging and multi-slice CT, European Journal of Radiology, vol.81, issue.4, pp.683-691, 2012.

M. Bruegel, J. Gaa, S. Waldt, K. Woertler, K. Holzapfel et al., Diagnosis of Hepatic Metastasis: Comparison of Respiration-Triggered Diffusion-Weighted Echo-Planar MRI and Five T2-Weighted Turbo Spin-Echo Sequences, American Journal of Roentgenology, vol.191, issue.5, pp.1421-1429, 2008.

G. D?assignies, P. Fina, O. Bruno, M. Vullierme, F. Tubach et al., High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging, Radiology, vol.268, issue.2, pp.390-399, 2013.

L. P. Lavelle, A. C. O'neill, C. J. Mcmahon, C. P. Cantwell, E. J. Heffernan et al., Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?, Clinical Radiology, vol.71, issue.9, pp.863-868, 2016.

A. Shenoy-bhangle, V. Baliyan, H. Kordbacheh, A. R. Guimaraes, and A. Kambadakone, Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates, World Journal of Hepatology, vol.9, issue.26, p.1081, 2017.

B. Taouli and D. Koh, Diffusion-weighted MR Imaging of the Liver, Radiology, vol.254, issue.1, pp.47-66, 2010.

T. Parikh, S. J. Drew, V. S. Lee, S. Wong, E. M. Hecht et al., Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging, Radiology, vol.246, issue.3, pp.812-822, 2008.

B. Taouli, V. Vilgrain, E. Dumont, J. Daire, B. Fan et al., Evaluation of Liver Diffusion Isotropy and Characterization of Focal Hepatic Lesions with Two Single-Shot Echo-planar MR Imaging Sequences: Prospective Study in 66 Patients, Radiology, vol.226, issue.1, pp.71-78, 2003.

L. Bihan, D. Poupon, C. Amadon, A. Lethimonnier, and F. , Artifacts and pitfalls in diffusion MRI, J Magn Reson Imaging JMRI. sept, vol.24, issue.3, pp.478-88, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00349658

A. Huppertz, T. Balzer, A. Blakeborough, J. Breuer, A. Giovagnoni et al., Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid?enhanced MR Images with Intraoperative Findings, Radiology, vol.230, issue.1, pp.266-275, 2004.

C. J. Zech, P. Korpraphong, A. Huppertz, T. Denecke, M. Kim et al., Randomized multicentre trial of gadoxetic acid-enhanced MRIversusconventional MRI or CT in the staging of colorectal cancer liver metastases, British Journal of Surgery, vol.101, issue.8, pp.1035-1035, 2014.

R. G. Beets-tan, Randomized multicentre trial of gadoxetic acid-enhanced MRIversusconventional MRI or CT in the staging of colorectal cancer liver metastases (Br J Surg2014; 101: 613-621), British Journal of Surgery, vol.101, issue.6, pp.622-622, 2014.

K. H. Lee, J. M. Lee, J. H. Park, J. H. Kim, H. S. Park et al., MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic Acid, Korean Journal of Radiology, vol.14, issue.6, p.894, 2013.

S. Palmucci, Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI, World Journal of Hepatology, vol.6, issue.7, p.477, 2014.

M. H. Lee, S. H. Kim, M. J. Park, C. K. Park, and H. Rhim, Gadoxetic Acid?Enhanced Hepatobiliary Phase MRI and High-b-Value Diffusion-Weighted Imaging to Distinguish Well-Differentiated Hepatocellular Carcinomas From Benign Nodules in Patients With Chronic Liver Disease, American Journal of Roentgenology, vol.197, issue.5, pp.W868-W875, 2011.

B. Chen, C. Hsu, C. Yu, S. Wei, J. Kao et al., Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients, European Radiology, vol.22, issue.1, pp.171-180, 2011.

J. Daire, B. Leporq, V. Vilgrain, B. E. Van-beers, S. Schmidt et al., Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes, European Journal of Drug Metabolism and Pharmacokinetics, vol.42, issue.4, pp.657-667, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01917871

A. Muhi, T. Ichikawa, U. Motosugi, H. Sou, H. Nakajima et al., Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI, Journal of Magnetic Resonance Imaging, vol.34, issue.2, pp.326-335, 2011.

U. Motosugi, T. Ichikawa, H. Morisaka, H. Sou, A. Muhi et al., Detection of Pancreatic Carcinoma and Liver Metastases with Gadoxetic Acid?enhanced MR Imaging: Comparison with Contrast-enhanced Multi?Detector Row CT, Radiology, vol.260, issue.2, pp.446-453, 2011.

N. Seo, M. Park, K. Han, K. H. Lee, S. H. Park et al., Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents, Cancer Research and Treatment, vol.50, issue.1, pp.60-70, 2018.

D. Koh, D. J. Collins, T. Wallace, I. Chau, and A. M. Riddell, Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases, The British Journal of Radiology, vol.85, issue.1015, pp.980-989, 2012.

J. Y. Cho, Y. J. Lee, H. Han, Y. Yoon, J. Kim et al., Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer, World Journal of Surgery, vol.39, issue.5, pp.1161-1166, 2015.

D. M. Koh, G. Brown, A. M. Riddell, E. Scurr, D. J. Collins et al., Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination, European Radiology, vol.18, issue.5, pp.903-910, 2008.

M. Tanaka, Y. Kishi, M. Esaki, S. Nara, M. Miyake et al., Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases, Annals of Surgical Oncology, vol.23, issue.12, pp.3991-3998, 2016.

E. Neri, M. A. Bali, A. Ba-ssalamah, P. Boraschi, G. Brancatelli et al., ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents, European Radiology, vol.26, issue.4, pp.921-931, 2015.

E. M. Merkle, C. J. Zech, C. Bartolozzi, M. R. Bashir, A. Ba-ssalamah et al., Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging, European Radiology, vol.26, issue.3, pp.674-682, 2015.

B. Kaya and Z. Koc, Diffusion-weighted MRI and optimal b-value for characterization of liver lesions, Acta Radiologica, vol.55, issue.5, pp.532-542, 2014.

J. D. Ferris, P. A. Bloom, P. R. Goddard, and C. Collins, Quantification of melanin and iron content in uveal malignant melanomas and correlation with magnetic resonance image., British Journal of Ophthalmology, vol.77, issue.5, pp.297-301, 1993.

J. H. Burdette, A. D. Elster, and P. E. Ricci, Acute Cerebral Infarction: Quantification of Spin-Density and T2 Shine-through Phenomena on Diffusion-weighted MR Images, Radiology, vol.212, issue.2, pp.333-339, 1999.

L. D. Rothermel, A. C. Sabesan, D. J. Stephens, S. S. Chandran, B. C. Paria et al., Identification of an Immunogenic Subset of Metastatic Uveal Melanoma, Clinical Cancer Research, vol.22, issue.9, pp.2237-2249, 2015.

L. T. Mainardi, K. M. Passera, A. Lucesoli, P. Potepan, E. Setti et al., A method for dynamic subtraction MR imaging of the liver, BMC Medical Imaging, vol.6, issue.1, p.5, 2006.